In preclinical research, FOXO4-DRI has been investigated as a senescence-targeting tool for studying cellular aging, stress responses, and tissue homeostasis
BPC-157 peptide therapy is gaining attention as an advanced option within regenerative medicine peptides, especially for individuals struggling with chronic gut issues, inflammation, or delayed tissue healing
RESULTS Here, to evidence a link between inflammatory bowel disease and multiple sclerosis that may be useful in practice, BPC 157 was used per-orally in rats subjected to cysteamine enema + colon-colon anastomosis colitis (9-11) and over-dose cuprizone application, a multiple sclerosis suited toxic experimental model (12)
(2000) PSD-95 involvement in maturation of excitatory synapses
Supports physician-directed treatment plans